Randomized Controlled Trial of Strain-Specific Probiotic Formulation (Renadyl) in Dialysis Patients

Table 2

Means.

Variable	Tx period	𝑁	Mean	Std. Dev.	Median	Min	Max
White blood cells (WBC)	Base	22	6.36	1.33	6.33	3.92	9.45
	Placebo (PL)	21	6.07	1.55	5.48	3.78	10.07
	Treatment (Tx)	21	5.57	1.17	5.75	3.46	8.04
C-reactive protein (CRP)	Base	21	8.89	9.65	5.00	0.30	40.00
	PL	18	11.28	19.36	5.31	0.51	85.00
	Tx	19	5.10	3.80	4.00	0.30	14.00
Total indoxyl glucuronide (TIG)	Base	22	0.75	0.23	0.70	0.37	1.31
	PL	22	0.75	0.25	0.73	0.33	1.30
	Tx	22	0.67	0.21	0.67	0.30	1.19